Research news A University of Texas at El Paso study has found that people with type 2 diabetes or obesity who used glucagon-like peptide-1 receptor agonists had lower odds of alcohol, opioid, nicotine and cocaine use disorders, although researchers said clinical trials were needed before the drugs could be considered for addiction treatment A study led by researchers at The University of Texas at El Paso, USA, has found that the use of diabetes and weight loss medicines such as Ozempic was associated with a lower risk of alcohol, opioid, nicotine and cocaine use disorders
Transparency matters here, and any credible resource should address this honestly
In another study, treatment with CoQ 10 (500 mg/kg/day, gavage) reduced LPO and elevated GSH levels and total antioxidant capacity (TAC) values, and SOD and glutathione peroxidase (GPx) activities in both brain areas of mice
Understanding Henry Meds' clinical credentialing, pharmacy sourcing, and pricing model is essential for patients evaluating telehealth GLP-1 options
)
